---
title: "CARMELO AGIUS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0880a7cd-1bb6-5352-b943-e34dd4aeb13d
json: https://whiteintel.dev/api/public/dossier/0880a7cd-1bb6-5352-b943-e34dd4aeb13d
identifier: icij:icijol-56058721
jurisdiction: MT
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# CARMELO AGIUS

**Type:** Organization  
**Jurisdiction:** MT  
**Identifier:** `icij:icijol-56058721`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/0880a7cd-1bb6-5352-b943-e34dd4aeb13d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0880a7cd-1bb6-5352-b943-e34dd4aeb13d  

## Ownership & control

### Holdings / subsidiaries

- **ASSOCIATED DRUG COMPANY LIMITED** (shareholder of) — https://whiteintel.dev/entity/c5c49e16-a2ad-5409-b353-86b300c29e0a

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/56058721

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CARMELO AGIUS**. Human view: https://whiteintel.dev/entity/0880a7cd-1bb6-5352-b943-e34dd4aeb13d · Structured JSON: https://whiteintel.dev/api/public/dossier/0880a7cd-1bb6-5352-b943-e34dd4aeb13d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._